We are live on
!
Find out more
PCM
Pavaki Capital Management Portfolio holdings
AUM
$287M
This Fund
S&P 500
This Quarter
Est. Return
+12.26%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
–
Cap. Flow
+$138M
Cap. Flow
% of AUM
54.05%
Top 10 Holdings %
Top 10 Hldgs %
57.32%
Holding
131
New
131
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Milestone Pharmaceuticals
MIST
|
+$18.3M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$13.2M |
| 3 |
ARS Pharmaceuticals
SPRY
|
+$11.4M |
| 4 |
B
Barrick Mining
B
|
+$7.28M |
| 5 |
Walt Disney
DIS
|
+$6.72M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 44.5% |
| 2 | Healthcare | 29.54% |
| 3 | Materials | 10.85% |
| 4 | Communication Services | 4.97% |
| 5 | Technology | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVO
101
Novo Nordisk
NVO
$169B
| $229K | 0.09% |
+4,500
| New | +$230K |
|
102
First American
FAF
$6.54B
| $227K | 0.09% |
+3,700
| New | +$232K |
|
103
Shell
SHEL
$271B
| $220K | 0.09% |
+3,000
| New | +$221K |
|
104
Johnson Outdoors
JOUT
$464M
| $212K | 0.08% |
+5,000
| New | +$207K |
|
|
FISV
105
Fiserv Inc
FISV
$24.1B
| $202K | 0.08% |
+3,000
| New | +$251K |
|
|
RMAX
106
DELISTED
RE/MAX Holdings
RMAX
| $190K | 0.07% |
+25,000
| New | +$203K |
|
107
Greenlight Captial
GLRE
$481M
| $190K | 0.07% |
+13,000
| New | +$171K |
|
|
CPRX
108
DELISTED
Catalyst Pharmaceutical
CPRX
| $187K | 0.07% |
+8,000
| New | +$178K |
|
109
PUT
Super Micro Computer
SMCI
$26.9B
| $176K | 0.07% |
+6,000
| New | +$247K |
|
110
PUT
ProShares Ultra S&P500
SSO
$8.46B
| $174K | 0.07% |
+3,000
| New | +$172K |
|
111
BP
BP
$112B
| $174K | 0.07% |
+5,000
| New | +$175K |
|
112
Halliburton
HAL
$26.3B
| $170K | 0.07% |
+6,000
| New | +$158K |
|
113
Enel Chile
ENIC
$5.87B
| $161K | 0.06% |
+40,000
| New | +$154K |
|
114
PUT
Invesco Semiconductors ETF
PSI
$2.87B
| $158K | 0.06% |
+2,000
| New | +$153K |
|
115
Navigator Holdings
NVGS
$1.41B
| $156K | 0.06% |
+9,000
| New | +$150K |
|
116
PUT
Global X Artificial Intelligence & Technology ETF
AIQ
$10.3B
| $153K | 0.06% |
+3,000
| New | +$152K |
|
117
Eldorado Gold
EGO
$10.1B
| $144K | 0.06% |
+4,000
| New | +$120K |
|
118
Gold Royalty Corp
GROY
$707M
| $141K | 0.06% |
+35,000
| New | +$134K |
|
119
Viking Therapeutics
VKTX
$4B
| $141K | 0.06% |
+4,000
| New | +$142K |
|
120
Legend Biotech
LEGN
$3.66B
| $137K | 0.05% |
+6,300
| New | +$180K |
|
121
Pebblebrook Hotel Trust
PEB
$2.11B
| $136K | 0.05% |
+12,000
| New | +$132K |
|
122
AGNC Investment
AGNC
$11.2B
| $129K | 0.05% |
+12,000
| New | +$123K |
|
123
Oshkosh
OSK
$8.13B
| $126K | 0.05% |
+1,000
| New | +$129K |
|
124
Cass Information Systems
CASS
$687M
| $125K | 0.05% |
+3,000
| New | +$122K |
|
125
Sportradar
SRAD
$3.42B
| $116K | 0.05% |
+5,000
| New | +$120K |
|
Similar funds
OCM
RSC
MC
QFW
SRWM
ORC
MPAM
AWMT
Pavaki Capital Management's Q4 2025 Portfolio in Review
Q4 2025 is the first quarter with a 13F filing on record for Pavaki Capital Management, which disclosed 131 positions worth $255M. Its ten largest holdings account for 57% of the portfolio.
Its largest position is Milestone Pharmaceuticals: 8,498,915 shares worth $17.2M.
By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, followed by Healthcare and Materials.
- Pavaki Capital Management's largest Q4 2025 buy was Milestone Pharmaceuticals: 8,498,915 shares worth $17.2M.
- Pavaki Capital Management's ten largest holdings make up 57% of its $255M portfolio in Q4 2025.
- Pavaki Capital Management disclosed 131 positions in Q4 2025, its first 13F filing on record.
Based on Pavaki Capital Management's 13F filing for Q4 2025, filed 7 Aug 2026.